[HTML][HTML] Vaccine‐induced immune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCOV19) vaccine–A case report
B Al Rawahi, H BaTaher, Z Jaffer, A Al‐Balushi… - Research and Practice …, 2021 - Elsevier
Vaccination with ChAdOx1 nCov‐19 can result in vaccine‐induced immune thrombotic
thrombocytopenia (VITT). This phenomenon mimics heparin‐induced thrombocytopenia
(HIT), yet it does not require heparin as a trigger. HIT screen/ELISA along with optical
density and functional assay are useful in diagnosis. A 64‐year‐old man presented to the
emergency department with intermittent fever and persistent, dull, nonspecific abdominal
pain 7 days after the first dose of ChAdOx1 nCov‐19 vaccine. Laboratory results showed …
thrombocytopenia (VITT). This phenomenon mimics heparin‐induced thrombocytopenia
(HIT), yet it does not require heparin as a trigger. HIT screen/ELISA along with optical
density and functional assay are useful in diagnosis. A 64‐year‐old man presented to the
emergency department with intermittent fever and persistent, dull, nonspecific abdominal
pain 7 days after the first dose of ChAdOx1 nCov‐19 vaccine. Laboratory results showed …